| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/07/2005 | US20050149998 Transgenic mouse embryonic stem cells for use as models in expression of heterologous genes |
| 07/07/2005 | US20050149995 Using transgenic animal cells as bioreactor for propagation of connective tissue protein for use in treatment of collagen diseases |
| 07/07/2005 | US20050149994 Rapidly maturing fluorescent proteins and methods for using the same |
| 07/07/2005 | US20050149993 Transgenic mouse for use as model in identifying modulators for prevention and treatment of circadian rythm disorders |
| 07/07/2005 | US20050148772 Methods and compositions for detecting polynucleotide duplex damage and errors |
| 07/07/2005 | US20050148765 Expression vector comprising nucleotide sequences coding cell cycle regulatory protein for use as tool in identifying modulators for prevention and treatment of cell proliferative disorders |
| 07/07/2005 | US20050148761 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 07/07/2005 | US20050148537 Immunostimulatory nucleic acid molecules |
| 07/07/2005 | US20050148535 Inducing apoptosis in cancer cells; expression vectors, cells; kits |
| 07/07/2005 | US20050148531 Antisense agents; blocking agents (biotin); high throughput screening |
| 07/07/2005 | US20050148530 useful in modulating vascular endothelial growth factor (VEGF) and/or vascular endothelial growth factor receptor (e.g., VEGFR) gene expression; used in therapeutic, diagnostic, target validation, and genomic discovery |
| 07/07/2005 | US20050148528 Via antisense oligonucleotides that inhibit the expression of raf-1 gene, formulated in liposomes with enhanced penetration into cells; free of chemotherapy/radiation treatments |
| 07/07/2005 | US20050148527 Catalytic nucleic acids; ribozymes; translation inhibition; gene expression inhibition; for treating cardiovascular disease; for neovascularization induction in heart tissue |
| 07/07/2005 | US20050148526 Methods of obtaining isoform specific expression in mammalian cells |
| 07/07/2005 | US20050148525 Nucleic acid markers |
| 07/07/2005 | US20050148516 Sugar transferase gnt-v having angiogenic effect |
| 07/07/2005 | US20050148513 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 07/07/2005 | US20050148510 Protein with a hedgehog N-terminal domain covalently bound to a polypeptide with 10-30 hydrophobic amino acids, C 8-24 aliphatic, saturated or unsaturated hydrocarbon residues, or a hydrophobic thio group |
| 07/07/2005 | US20050148502 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43 |
| 07/07/2005 | US20050148078 Bovine immunodeficiency virus (BIV) based vectors |
| 07/07/2005 | US20050148077 Bovine immunodeficiency virus (BIV) based vectors |
| 07/07/2005 | US20050148076 Packaging cell lines for generation of high titers of recombinant AAV vectors |
| 07/07/2005 | US20050148075 With binding specificity for target nucleotides containing one or GNN triplets; regulating gene expression |
| 07/07/2005 | US20050148072 Human liver progenitors |
| 07/07/2005 | US20050148062 Transgenic microorganisms comprising apoptosis associated genes for use as tools in identifying modulators for prevention and treatment of cell proliferative disorders |
| 07/07/2005 | US20050148061 Hybrid plasmid pzzsa coding the synthesis of angiogenis of angiogenin protein and escherichia coli bl21(des) pzzsa strain as the the superoducer of the recombinant chimeric protein of human angiogenin |
| 07/07/2005 | US20050148059 Subtilisin comprising b-cell epitope for use in detergents, textile treatment, liquid soaps, cosmetics and contact lense cleaning solutions |
| 07/07/2005 | US20050148058 Protein stabilization |
| 07/07/2005 | US20050148057 Carbonyl reductases, polynucleotides comprising DNA encoding the same, methods for producing the same, and methods for producing optically active alcohol utilizing the same |
| 07/07/2005 | US20050148054 Methods for the production of tyrosine, cinnamic acid and para-hydroxycinnamics acid |
| 07/07/2005 | US20050148045 Using transgenic microorganism comprising gene coding fostriecin polyketide synthase to generates antitumor antibiotics; bioreactors; anticarcinogenic agents |
| 07/07/2005 | US20050148037 Method for examining WT1-related disease |
| 07/07/2005 | US20050148035 fusion proteins comprising insulin-like growth factor binding protein-3 fragments of human native-sequence, linked to a synthetic polypetide, used in cell-based assays, as IGF antagonists, in mapping IGF binding sites on other molecules such as wild-type IGFBP-3 and IGF agonist peptides |
| 07/07/2005 | US20050148028 Matrix membrane fusion protein with improved solubility in membrane-free and detergent-free aqueous environments for use in identifying modulators of membrane transport |
| 07/07/2005 | US20050148018 Methods of identifying inverse agonists of the serotonin 2A receptor |
| 07/07/2005 | US20050148017 Antisense oligonucleotides against tenascin for the treating of vitiligo |
| 07/07/2005 | US20050148014 Regulation of human P2Y1-like G protein-coupled receptor |
| 07/07/2005 | US20050148013 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/07/2005 | US20050148012 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 07/07/2005 | US20050148008 Compositions and methods relating to ovarian specific genes and proteins |
| 07/07/2005 | US20050148007 Using yeast culture system comprising deletion and bioluminescent markers as tool in screening test agents; carcinogen testing |
| 07/07/2005 | US20050148006 Using modulator of guanosine diphosphate mannose-4,6 dehydratase for prevention and treatment of arthritis, sepsis, asthma, infection, stroke, reperfusion injury and organ transplant rejection |
| 07/07/2005 | US20050147993 Recombinant high mobility polypeptide comprisingprotein transduction domain linked to non-nuclear organelle targeting signal; gene transfer vector |
| 07/07/2005 | US20050147988 Recombinant protein for use as tool in detection of helicobacter infection; immunodiagnostics |
| 07/07/2005 | US20050147974 Luminescent silica gel particles containing transparent silica gel matrix and comprising changeable luminescence intensities; for use as visualizing tools in biochemical and medical analytics and diagnostics |
| 07/07/2005 | US20050147972 Method of diagnosis of inflammatory diseases using calgranulin c |
| 07/07/2005 | US20050147971 Biomolecule transduction motif mph-1-btm and the use thereof |
| 07/07/2005 | US20050147969 Genes associated with mast cell activation |
| 07/07/2005 | US20050147968 Expression vector comprising nucleotide sequence coding glucose isomerase for use as tool in transfer, enhancement and stability of exogenous gene expression |
| 07/07/2005 | US20050147967 Expression vector comprising nucleotide sequences coding apoptosis polypeptide for use in identifying modulators for treatment and prevention of nervous system disorders; rational drug design |
| 07/07/2005 | US20050147964 Using scanning probe microscopy to identify phage polypeptide/peptides that bind to preferential geometric shapes |
| 07/07/2005 | US20050147692 Methods, compositions and devices for inducing stasis in tissues and organs |
| 07/07/2005 | US20050147632 Virally infected plants as a source of insect reppellants/attractents |
| 07/07/2005 | US20050147623 Recombinant parainfluenza virus expression systems and vaccines |
| 07/07/2005 | US20050147622 Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules |
| 07/07/2005 | US20050147615 Compositions and methods for the therapy and diagnosis of colon cancer |
| 07/07/2005 | US20050147612 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 07/07/2005 | US20050147604 Means and methods for diagnosing and treating affective disorders |
| 07/07/2005 | US20050147600 Angiotensin converting enzyme homolog and uses therefor |
| 07/07/2005 | US20050147592 Correcting underlying genetic defect; delivering heterologous gene encoding metabolic protein causing transduction of cells resulting in expression from transformed cell genetics |
| 07/07/2005 | US20050147590 Immunogenic minicells and methods of use |
| 07/07/2005 | US20050145581 Underdrain for filtration membrane |
| 07/07/2005 | DE10358137A1 Verfahren und Kit zur Isolierung von RNA A method and kit for the isolation of RNA |
| 07/07/2005 | DE10246186B4 Abbau und Modifizierung von Silicaten und Siliconen durch Silicase und Verwendung des reversiblen Enzyms Degradation and modification of silicates and silicones by silicase and use of the reversible enzyme |
| 07/07/2005 | CA2773169A1 Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
| 07/07/2005 | CA2648274A1 Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
| 07/07/2005 | CA2551546A1 Preventive/remedy for cancer |
| 07/07/2005 | CA2551543A1 Method of suppressing cancer |
| 07/07/2005 | CA2551503A1 Gene expression technique |
| 07/07/2005 | CA2551496A1 2-micron family plasmid and use thereof |
| 07/07/2005 | CA2551012A1 Indole-diterpene biosynthesis |
| 07/07/2005 | CA2550489A1 Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
| 07/07/2005 | CA2550258A1 Oligomeric compounds for the modulation of bcl-2 |
| 07/07/2005 | CA2550233A1 Transgenic plants with increased yield comprising as transgene a cyclin a nucleic acid and methods for making the same |
| 07/07/2005 | CA2549982A1 Engineered templates and their use in single primer amplification |
| 07/07/2005 | CA2549720A1 Cell transfecting formulations of small interfering rna, related compositions and methods of making and use |
| 07/07/2005 | CA2549249A1 Muteins of fibroblast growth factor 21 |
| 07/07/2005 | CA2549081A1 Variable valve apparatus and methods |
| 07/07/2005 | CA2548452A1 Medicament comprising inhibitors of long pentraxin ptx3 |
| 07/07/2005 | CA2548065A1 Anti-igf-i receptor antibody |
| 07/07/2005 | CA2546752A1 Nucleic acid amplification methods |
| 07/07/2005 | CA2546502A1 A method for gene amplification |
| 07/07/2005 | CA2545696A1 An oncolytic adenovirus |
| 07/07/2005 | CA2544562A1 Bispecific antibodies |
| 07/06/2005 | EP1550870A1 Method for detecting biochemical reagin biochip |
| 07/06/2005 | EP1550729A1 Target binding polypeptide comprising an IG-like VL domain linked to an IG-like VH domain |
| 07/06/2005 | EP1550722A1 Serotype of adenovirus and uses thereof |
| 07/06/2005 | EP1550721A2 Esterases |
| 07/06/2005 | EP1550720A1 Mutated androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof |
| 07/06/2005 | EP1550719A1 Methods and medicament for inhibition the expression of a defined gene |
| 07/06/2005 | EP1550718A1 Method of detecting base mutation |
| 07/06/2005 | EP1550713A2 Gas driven gene delivery instrument |
| 07/06/2005 | EP1550672A1 Chimeric antagonist anth1 |
| 07/06/2005 | EP1550463A1 Preparation for facilitating site-specific gene conversion and preparation for gene therapy |
| 07/06/2005 | EP1550074A1 Prediction by collective likelihood from emerging patterns |
| 07/06/2005 | EP1549951A2 Semaphorin-like proteins and methods of using same |
| 07/06/2005 | EP1549940A2 Transgenic animal model for spliceosome-mediated rna trans-splicing |
| 07/06/2005 | EP1549769A2 Gene expression profiling from ffpe samples |
| 07/06/2005 | EP1549767A2 Modulation of forkhead box o1a expression |
| 07/06/2005 | EP1549763A2 Prophylactic and therapeutic hiv aptamers |